Security key
74168J101
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 21,453,869
- Total 13F value
- $65,631,604
- Share change
- +459,922
- SEC-reported price per share
- $3.06
- Number of holders
- 42
- Value change
- +$1,368,418
- Number of buys
- 20
- Number of sells
- 16
- Shares outstanding
- 181,672,212
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2026
Institutions
42
Top holders
10
PRME full security history
Ownership snapshot
Full 13F holder table
Prime Medicine, Inc. SEC filings
Prime Medicine, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 74168J101
Recent filing periods:
Ownership snapshot
Top reported holders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
GV 2019, L.P.
Disclosed value leader
GV 2019 GP, L.L.C.
Comparable rows
5/15
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
10 rows are not safely comparable across share classes.
13D/G row: GV 2019, L.P.
Showing 1-6 of 15 holder rows.
Quick read
GV 2019, L.P. leads the comparable SEC ownership view at 12%.
5 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens GV 2019, L.P.'s linked filing trail.
Comparable ownership
Top 5
GV 2019, L.P.
12%
ARCH Venture Fund XII, L.P.
10%
Newpath Partners, L.P.
4.7%
FMR LLC
3.8%
T. Rowe Price Investment Manageme...
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| GV 2019, L.P. |
13D/G
Alphabet Holdings LLC
|
12%
Reported 13D/G
· 30 Sep 2025
|
$91,756,239
16,562,498 shares
|
$0 | 30 Sep 2025 |
| ARCH Venture Fund XII, L.P. |
13D/G
Robert Nelsen
|
10%
Reported 13D/G
· 07 Aug 2025
|
$80,853,607
18,587,036 shares
|
$0 | 07 Aug 2025 |
| Newpath Partners, L.P. |
13D/G
|
4.7%
Reported 13D/G
· 31 Dec 2024
|
$9,769,086
6,105,679 shares
|
$0 | 31 Dec 2024 |
| FMR LLC |
3/4/5
13D/G
13F
Other* · Company
|
3.8%
Reported 13D/G
· 30 Sep 2025
|
$126,699,612
8,462,946 shares
|
— | 24 Oct 2022 |
| T. Rowe Price Investment Management, Inc. |
13D/G
13F
Company
|
3.3%
Reported 13D/G
· 31 Dec 2025
|
$25,659,383
5,995,183 shares
|
-$13,874,784 | 31 Dec 2025 |
| GV 2019 GP, L.L.C. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$177,594,643
11,862,498 shares
|
— | 20 Jun 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
42
Shares
21,453,869
Rows available
42
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
186
Q3 2026 holders
42
Holder diff
-144
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend